re: cogstate to move...... CogState in diagnostic trial deal
Biotech CogState has signed a deal with The Centres for Disease Control and Prevention in the United States to use CogState's computer-based cognitive test in a trial involving HIV patients to detect early signs of HIV-related dementia.
"It is hard to overstate the importance of this win for the company because US government agencies are obligated to first review US products," CogState chief executive Peter Bick said.
"The $21,000 value of the deal is useful but the true value is in the credibility it bestows for us in the largest market in the world, the US." AAP
http://newsstore.com.au/apps/viewDocument.ac?page=1&sy=afr&kw=Delhi&pb=afr&dt=selectRange&dr=1month&so=relevance&sf=headline&sf=text&rc=10&rm=200&sp=0&clsPage=1&docID=AFR040816IG3LT44OIM4
re: cogstate to move...... CogState in diagnostic trial...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.000(0.00%) |
Mkt cap ! $195.5M | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.15 | $1.15 | $22.84K | 19.95K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 5150 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 2934 | 3 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| CGS (ASX) Chart |